ACADIA Pharmaceuticals
ACAD
#3370
Rank
NZ$5.87 B
Marketcap
$35.28
Share price
3.43%
Change (1 day)
-12.79%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): NZ$0.22 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.92 Billion. In 2023 the company made an earning of -NZ$88.51 Million, an increase over its 2022 earnings that were of -NZ$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.22 B-348.72%
2023 -NZ$88.51 Million-76.09%
2022 -NZ$0.38 Billion27.41%
2021 -NZ$0.3 Billion-40.38%
2020 -NZ$0.49 Billion19.88%
2019 -NZ$0.41 Billion-3.92%
2018 -NZ$0.43 Billion-15.04%
2017 -NZ$0.5 Billion6.33%
2016 -NZ$0.47 Billion64.55%
2015 -NZ$0.29 Billion77.47%
2014 -NZ$0.17 Billion143.69%
2013 -NZ$65.81 Million81.93%
2012 -NZ$36.18 Million-8.73%
2011 -NZ$39.63 Million-251.39%
2010 NZ$26.17 M-133.2%
2009 -NZ$78.86 Million-30.82%
2008 -NZ$0.12 Billion6.43%
2007 -NZ$0.11 Billion25.89%
2006 -NZ$85.07 Million36.99%
2005 -NZ$62.1 Million37.22%
2004 -NZ$45.26 Million19.96%
2003 -NZ$37.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$64.99 Million-127.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.04 B 4,979.27%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.60 B 7,325.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.24 B 12,659.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.54 Billion-6,229.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$67 Million-128.26%๐Ÿ‡บ๐Ÿ‡ธ USA